Effects of risk factors on the development and mortality of early-and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea MY Chun, W Chae, SW Seo, H Jang, J Yun, DL Na, D Kang, J Lee, ... Alzheimer's Research & Therapy 16 (1), 1-11, 2024 | | 2024 |
Association of Heart Failure With Cognitive Decline and Development of Mild Cognitive Impairment and Dementia M Jung, LG Apostolova, S Gao, HN Burney, D Lai, AJ Saykin, SJ Pressler Journal of Cardiovascular Nursing 39 (3), E80-E85, 2024 | | 2024 |
Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from Early Onset Alzheimer’s Disease (N4. 002) J Appleton, Q Funk, PZ Fregonara, M Yu, A Faridar, M Nakawah, ... Neurology 102 (17_supplement_1), 6312, 2024 | | 2024 |
Genetic associations with dementia‐related proteinopathy: Application of item response theory Y Katsumata, DW Fardo, LMP Shade, X Wu, SD Karanth, TJ Hohman, ... Alzheimer's & Dementia 20 (4), 2906-2921, 2024 | 1 | 2024 |
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration AM Staffaroni, AL Clark, JC Taylor, HW Heuer, M Sanderson-Cimino, ... JAMA Network Open 7 (4), e244266-e244266, 2024 | | 2024 |
Validation of and Demographically Adjusted Normative Data for the Learning Ratio Derived from the RAVLT in Robustly Intact Older Adults (vol 37, pg 981, 2022) DB Hammers, RJ Spencer, LG Apostolova ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024 | | 2024 |
Biomarker-based staging of Alzheimer disease: rationale and clinical applications J Therriault, SE Schindler, G Salvadó, TA Pascoal, AL Benedet, ... Nature Reviews Neurology, 1-13, 2024 | 3 | 2024 |
Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease M Yu, SL Risacher, KT Nho, Q Wen, AL Oblak, FW Unverzagt, ... Cell Reports 43 (2), 2024 | 1 | 2024 |
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis M Chapleau, R La Joie, K Yong, F Agosta, IE Allen, L Apostolova, J Best, ... The Lancet Neurology 23 (2), 168-177, 2024 | 5 | 2024 |
Associations between social network characteristics and brain structure among older adults MK Manchella, PE Logan, BL Perry, S Peng, SL Risacher, AJ Saykin, ... Alzheimer's & Dementia 20 (2), 1406-1420, 2024 | 1 | 2024 |
Edge time series components of functional connectivity and cognitive function in Alzheimer’s disease EJ Chumin, SA Cutts, SL Risacher, LG Apostolova, MR Farlow, ... Brain Imaging and Behavior 18 (1), 243-255, 2024 | | 2024 |
TAF15 amyloid filaments in frontotemporal lobar degeneration S Tetter, D Arseni, AG Murzin, Y Buhidma, SY Peak-Chew, HJ Garringer, ... Nature 625 (7994), 345-351, 2024 | 6 | 2024 |
1978 Donanemab in early symptomatic Alzheimer’s Disease: Efficacy and safety in TRAILBLAZER-ALZ 2, Phase 3 Randomized Clinical Trial M Mintun, C Ritchie, P Solomon, JR Sims, S Salloway, O Hansson, ... Age and Ageing 53 (Supplement_1), afad246. 112, 2024 | | 2024 |
BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and Ethnicity DA Dempsey, R Deardorff, YC Wu, M Yu, LG Apostolova, J Brosch, ... medRxiv, 2023 | | 2023 |
Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial M Mintun, CW Ritchie, P Solomon, JR Sims, S Salloway, O Hansson, ... Alzheimer's & Dementia 19, e082733, 2023 | 5 | 2023 |
Relationship of structural and functional visual biomarkers with measures of amyloid, tau, and neurodegeneration across the AD continuum S Mathew, D WuDunn, D Mackay, A Vosmeier, EF Tallman, R Deardorff, ... Alzheimer's & Dementia 19, e079789, 2023 | | 2023 |
Transforming genetic data for a convolutional neural network using genotype posterior probability: Algorithm for handling incorrectly imputed multiallelic variants for multiple … J Bae, KNH Nudelman, LG Apostolova Alzheimer's & Dementia 19, e078342, 2023 | | 2023 |
Etiology of white matter hyperintensities in autosomal dominant and sporadic Alzheimer disease Z Shirzadi, SA Schultz, WYW Yau, N Joseph-Mathurin, CD Fitzpatrick, ... JAMA neurology 80 (12), 1353-1363, 2023 | 14 | 2023 |
Females Derive Greater Neuroprotective Benefits from Social Connectedness than Males MK Manchella, PE Logan, BL Perry, S Peng, SL Risacher, AJ Saykin, ... Alzheimer's & Dementia 19, e081941, 2023 | | 2023 |
Gene co‐expression network analyses in Mild cognitive impairment V Dorsant‐Ardon, AB Sanjay, LM Rocha, RB Correia, LG Apostolova Alzheimer's & Dementia 19, e082238, 2023 | 1 | 2023 |